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Abstract 
Background 
Liver cirrhosis is a disease with high morbidity and mortality in Indonesia. The Child-Turcotte-Pugh classification is 
a noninvasive parameter to assess severity of liver cirrhosis. Meanwhile, the neutrophil/lymphocyte ratio can reflect person's 
immunity to liver cirrhosis.  
 
Objective 
This study was conducted to determine the conformity between neutrophil/lymphocyte ratio and Child-Turcotte-Pugh 
classification in assessing severity of liver cirrhosis. 
 
Methods 
Analytical observational study with Cohen’s Kappa conformity test was conducted in 86 liver cirrhosis patients. Data 
was retrieved by observing the medical records. Neutrophil count, lymphocyte count, hepatic encephalopathy, ascites, 
albumin, bilirubin, and INR were all recorded. Documented variables were analyzed by the Cohen’s Kappa conformity test. 
 
Results 
In Cohen’s Kappa conformity test, there was moderate conformity between neutrophil/lymphocyte ratio and Child-
Turcotte-Pugh classification in all samples (κ = 0.591 and p <0.001). Conformity between neutrophil/lymphocyte ratio and 
Child-Turcotte-Pugh classification based on age and gender was found to be κ = 0.777 at age ≤45 years, κ = 0.532 at age >45 
years, κ = 0.682 in male, and κ = 0.445 in female (p <0.001). The highest conformity is the substantial conformity between 
neutrophil/lymphocyte ratio and Child-Turcotte-Pugh classification obtained at age ≤45 years (κ = 0.777 and p <0.001) and 
male (κ = 0.682 and p <0.001). 
 
Conclusion 
There is moderate conformity between neutrophil/lymphocyte ratio and Child-Turcotte-Pugh classification in 
assessing severity of liver cirrhosis. Substantial conformity obtained at age ≤45 years and male gender. 
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Background 
Liver cirrhosis is the final stage of the diffuse process of progressive liver fibrosis characterized by 
distortion of liver architecture and regenerative nodule formation. Liver cirrhosis is the third highest 
cause of death in patients aged 45-46 years [1]. In 2017, there were 45,783,000 cases of liver cirrhosis in 
the world and 1,638,000 of them were new cases. [2] 
Indonesia is one of ten developing countries with the highest cases of liver cirrhosis according to 
the World Health Organization (WHO). [3-4] The prevalence of liver cirrhosis in Indonesia in 2007 was 
1.7% and increased to 3.5% in 2013. [5-6] Recent data recorded the mortality rate of liver cirrhosis in 
Indonesia according to gender by 52.7/100,000 population in men and 16.6/100,000 population in 
women. [4] 
Neutrophil/lymphocyte ratio is a parameter that can reflect a person's immunity against liver 
cirrhosis because neutrophils and lymphocytes play an important role in the course of the disease of liver 
cirrhosis.  [7-10] The neutrophil/lymphocyte ratio is a cheap, available and fast method to describe systemic 
inflammation, as well as complex pathophysiological processes that underlie the progression of liver 
cirrhosis.  [11-15] However, an increase in the neutrophil/lymphocyte ratio is not only found in patients 
with liver cirrhosis, but it is also found in patients suffering from infections, autoimmune diseases, HIV-
AIDS, malignancy, leukemia, or being pregnant so that the neutrophil/lymphocyte ratio cannot used if 
the patient with cirrhosis of the liver suffers from one of the accompaniers. [16] The neutrophil/lymphocyte 
ratio is obtained from laboratory results with a complete blood examination. The neutrophil/lymphocyte 
ratio can be calculated by dividing absolute neutrophil counts with absolute lymphocytes.  [17]  
The severity of liver cirrhosis can be measured using an objective, accurate and inexpensive scoring 
system such as the Child-Turcotte-Pugh classification and the Model of End-Stage Liver Disease 
(MELD).  [11, 18-19] The Child-Turcotte-Pugh classification and MELD have similar prognosis significance 
in many cases.  [20-21] However, in a recent study it was found that the Child-Turcotte-Pugh classification 
was intended to assess survival while MELD was intended to determine the optimal time for liver 
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transplantation.  [22] Therefore, the Child-Turcotte-Pugh scoring system can be used to measure the 
severity associated with the survival of patients with liver cirrhosis. 
In previous studies it was found that the neutrophil/lymphocyte ratio was significantly useful for 
predicting the prognosis of patients with liver cirrhosis. [23-25] The study was supported by research in 
Indonesia with a significant positive correlation between neutrophil/lymphocyte ratio and Child-
Turcotte-Pugh scores in patients with liver cirrhosis (r = 0.749 and p <0.0001).  [11] 
Liver cirrhosis is a disease that has a poor prognosis and Indonesia is one of the developing 
countries with high rates of morbidity and mortality of liver cirrhosis.  [26] Therefore, a study was 
conducted on the conformity test between the neutrophil/lymphocyte ratio and the Child-Turcotte-Pugh 
classification in assessing severity of liver cirrhosis in RSUP Dr. Mohammad Hoesin Palembang. 
The purpose of this study was to determine the conformity between the neutrophil/lymphocyte ratio 
and the Child-Turcotte-Pugh classification in assessing severity of liver cirrhosis. Identification of 
neutrophil/lymphocyte ratios and Child-Turcotte-Pugh classification in patients with liver cirrhosis in 
Indonesia can also illustrate the importance of improving early detection, early management and 
communication, information as well as education regarding the importance of treatment to prevent 
worsening of liver cirrhosis. 
 
Methods 
This study was an observational analytic study using the Cohen's Kappa conformity test conducted 
from January 2016 to October 2018. [27-28] The sample of this study was all liver cirrhosis patients who 
had undergone complete blood tests and liver function examinations during the period of January 2016 
to October 2018 at RSUP Dr. Mohammad Hoesin Palembang who fulfilled the inclusion criteria. The 
inclusion criteria are all patients aged 18–65 years old who had been diagnosed with liver cirrhosis by a 
Gastroenterology and Hepatology specialist. Patients necessarily had undergone complete blood tests 
and liver function examination during the period of January 2016 to October 2018 in the Internal 
Medicine Installation of RSUP Dr. Mohammad Hoesin Palembang. 
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The research data was obtained from the patients’ medical records. Factors studied included 
neutrophil count, lymphocyte count, hepatic encephalopathy, ascites, albumin, bilirubin, and INR. 
Diagnosis of liver cirrhosis is seen through diagnosis results in medical records. 
Univariate analysis was used to determine the characteristics of patients with liver cirrhosis based 
on age and gender. In addition, the distribution of patients was based on cut-off point from 
neutrophil/lymphocyte ratio and Child-Turcotte-Pugh classification. The bivariate analysis used was the 




Research had been conducted at RSUP Dr. Mohammad Hoesin Palembang and it was found that 
there were 297 liver cirrhosis patients from January 1, 2016 - October 31, 2018. Eighty six out of 297 
samples met the inclusion and exclusion criteria. 
Table 1. Liver Cirrhosis Patients Data (n=86) 
 
Characteristics n % 
Age   
≤45 years old 22 25.6% 
>45 years old 64 74.4% 
Gender   
Male 54 62.8% 
Female 32 37.2% 
BMI   
<17.0 2 2.3% 
17.0–18.4 13 15.1% 
18.5–25.0 56 65.1% 
25.1–27.0 4 4.7% 
>27.0 11 12.8% 
Etiology (Hepatitis)   
Hepatitis B 44 51.2% 
Hepatitis C 5 5.8% 
Hepatitis B dan C 2 2.3% 
Not Hepatitis 35 40.7% 
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Table 1 shows the characteristics of liver cirrhosis patients. Patients with liver cirrhosis in this 
study were aged 25-65 years old. The mean±SD age of liver cirrhosis patients is 51 ± 8.54 years old. 
Based on gender, men dominate with a percentage of 62.8%. BMI of liver cirrhosis patients had a 
mean±SD of 22.04 ± 4.24 kg/m2 and is dominated by patients with normal BMI (18.5–25.0). Meanwhile, 
the main etiology of patients with liver cirrhosis in Asia is hepatitis B and C infection so that hepatitis B 
infection is the highest in this study (51.2%). Liver cirrhosis patients with hepatitis B and C infections 
were obtained based on laboratory tests, namely HBsAg and anti-HCV. 
 
Table 2. Distribution of Major Complaint in Patients (n=86) 
 
Major Complaint n % 
Enlarged stomach 31 36.0% 
Black vomit and feces 15 17.4% 
Limp body 14 16.3% 
Black feces 10 11.6% 
Stomach cramp 9 10.5% 
Black vomit  3 3.5% 
Loss of consciousness 3 3.5% 
Icteric 1 1.2% 
 
In table 2, distribution of the main complaints showed that the most major complaints in liver 
cirrhosis patients who came to RSUP Dr. Mohammad Hoesin Palembang was enlarged stomach (31 
patients), black vomit and feces (15 patients), and limp body (14 patients). This main complaint is in 
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Table 3. Distribution of Clinical Findings in Patients (n=86) 
 
Clinical Findings n % 
Esophageal Varices   
Esophageal Varices 36 41.9% 
Not Esophageal Varices 50 58.1% 
Hepatic Encephalopathy   
Hepatic Encephalopathy 10 11.6% 
Not Hepatic Encephalopathy 76 88.4% 
Ascites   
Ascites 50 58.1% 
Not Ascites 36 41.9% 
 
The distribution of clinical findings in patients with liver cirrhosis is presented in table 3. Clinical 
findings in the form of esophageal varices, hepatic encephalopathy, and ascites are a form of 
hepatocellular failure and portal hypertension in patients with liver cirrhosis. 
 
Table 4. Distribution of Neutrophil/Lymphocyte Ratio and Child-Turcotte-Pugh Classification in Patients (n=86) 
 
Variable n % 
Neutrophil/Lymphocyte Ratio   
   ≤3,1482 21 24.4% 
   3,1483–6,5208  44 51.2% 
   ≥6,5209 21 24.4% 
Child-Turcotte-Pugh Classification   
   Child-Turcotte-Pugh A 19 22.1% 
   Child-Turcotte-Pugh B 33 38.4% 
   Child-Turcotte-Pugh C 34 39.5% 
 
Table 4 shows the distribution of neutrophil/lymphocyte ratio and the mean±SD in liver cirrhosis 
patients obtained is 4.77 ± 2.016. The minimum value of the neutrophil/lymphocyte ratio obtained was 
only 1.22 and the maximum value of the neutrophil/lymphocyte ratio obtained was 9.67. The cut-off 
point of neutrophil/lymphocyte ratio in liver cirrhosis patients was based on the 25th and 75th percentiles 
of IBM SPSS Statistic 23. Meanwhile, table 4 also presents the distribution of the Child-Turcotte-Pugh 
classification and it was found that liver cirrhosis patients in this study dominated by Child-Turcotte-
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Pugh C classification (39.5%). The Child-Turcotte-Pugh classification is determined based on the 
parameters for hepatic encephalopathy, ascites, albumin, bilirubin, and INR. 
 
Table 5. Conformity between Neutrophil/Lymphocyte Ratio and Child-Turcotte-Pugh Classification in Assessing 
Severity of Liver Cirrhosis 
 
Agreement κ p_value 
All Samples 0.591 0.000 
Age   
≤45 years old 0.777 0.000 
>45 years old 0.532 0.000 
Sex   
Male 0.682 0.000 
   Female 0.445 0.000 
 
Table 5 presents the value of conformity between the neutrophil/lymphocyte ratio and the Child-
Turcotte-Pugh classification. In all samples, moderate conformity was found between the 
neutrophil/lymphocyte ratio and the Child-Turcotte-Pugh classification (κ=0.591, p<0.001). Meanwhile, 




Liver cirrhosis patients, according to age and gender, were found to be higher at age >45 years 
(74.4%) and male gender (62.8%). Women aged ≤45 years have lower incidence of liver cirrhosis 
because the hormone estrogen, through ERβ (Estrogen Receptor β), is able to inhibit the activation and 
proliferation of liver cells which triggers the deposition of collagen, so that the fibrosis process in liver 
cirrhosis can be inhibited. [29-33] 
Most liver cirrhosis patients have a normal BMI (65.1%). This is not in accordance with studies in 
the United States that found that there was a significant increase in BMI in patients with liver cirrhosis. 
[34] Nutritional factors and the necessities fulfilled in Asia, especially developing countries together with 
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dominant factors such as infections (hepatitis B and C) cause lower mean BMI and even normal in liver 
cirrhosis patients in Indonesia. [3-4, 35-36] 
The distribution of hepatitis B in liver cirrhosis patients was found to be 51.2%. This was in 
accordance with previous studies which obtained a dominant percentage of hepatitis B which was 24.60% 
and 78.2%. [11, 13] However, liver cirrhosis patients who have hepatitis C have a mortality rate 25% higher 
than patients with hepatitis B. [15, 29, 37-38] 
The results obtained in this study related to hepatocellular failure and portal hypertension 
manifestations included 41.9% incidence with esophageal varices, 11.6% with hepatic encephalopathy, 
and 58.1% with ascites. In the previous study, it was found that there were 6% of liver cirrhosis patients 
with esophageal varices, 10% with hepatic encephalopathy, and 50% with ascites. [30, 39] From the two 
studies it was found that there were a significant increase in the incidence of esophageal varices. This 
was because the study was dominated by liver cirrhosis patients with the Child-Turcotte-Pugh 
classification C. Eighty-five percent of liver cirrhosis patients with the Child-Turcotte-Pugh C 
classification had esophageal varices. [40] 
The percentage of patients with neutrophil/lymphocyte ratios of 3.1483–6.5208 was obtained to be 
51.2% of the total sample. An increase in the neutrophil/lymphocyte ratio in patients with liver cirrhosis 
reflects an increase in neutrophils due to the chronic inflammatory process and a decrease in lymphocyte 
activity due to the suppression made by neutrophils through arginase, nitric oxide synthase (NOS), and 
reactive oxygen species (ROS). [7-8, 11-16] 
It was found that Child-Turcotte-Pugh C classification has results of 39.5%. In previous studies, it 
was found that the sample with the Child-Turcotte-Pugh B classification dominated with a percentage 
reaching 44.1% and 56.94%. [41-43] Liver cirrhosis patients with Child-Turcotte-Pugh C classification 
have a low survival rate. The 1-year and 2-year survival rate of liver cirrhosis patients with the Child-
Turcotte-Pugh C classification were 45% and 35%, respectively. [40] 
Conformity between neutrophil/lymphocyte ratio and Child-Turcotte-Pugh classification in 
assessing severity of liver cirrhosis in all samples was found to be at moderate agreement. Some theories 
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suggest that there is an increase in neutrophils and decrease in lymphocytes so that the ratio between the 
two increases in liver cirrhosis patients. [7-8, 16] In liver cirrhosis, the necroinflammatory process activates 
liver stellate cells. The liver stellate cells then produce cytokines that activate neutrophils so that an 
inflammatory response occurs. However, hepatocyte death in liver cirrhosis causes produced cytokines 
cannot be detoxified. As a result, cytokines activate neutrophils persistently so that the number of 
neutrophils in the body increases. [8, 11] 
Meanwhile, neutrophils also have a mechanism to suppress lymphocyte formation through 
arginase, NOS, and ROS. Neutrophils have a high amount of arginase in azurophilic granules, whereas 
T cell activation depends on the availability of body arginine. The release of neutrophil arginase through 
degranulation or apoptosis causes a decrease in body arginine so T cell activation becomes inhibited. [12-
14] 
Based on age categories, conformity was found to be lower in the age group >45 years old (elderly). 
In elderly, there is a decrease in the function of the body's immune system (immunosenescence) so that 
the activation and migration of neutrophils to the site of infection is inhibited.  [44-45] In addition, when 
there are severe and long-term infections, elderly patients can experience neutropenia due to the 
continuous stimulation of the Granulocyte-Colony Stimulating Factor (G-CSF) to the Common Myeloid 
Progenitor. The impact of immunonescence on lymphocytes can also be seen from a decrease in 
lymphocyte levels in both B and T lymphocytes.  [46] 
By gender, a lower level of conformity between neutrophil/lymphocyte ratio and Child-Turcotte-
Pugh classification was obtained in women. The estrogen hormone in women is able to inhibit the 
activation and proliferation of liver cells that activate neutrophils through ERβ (Estrogen Receptor β). 
As a result, neutrophil levels in women with liver cirrhosis do not increase as much as in men, although 
worsening conditions in cirrhosis of the liver continue. [32] 
The research conducted is limited on Cohen’s Kappa conformity test because it only assess the 
compatibility between two methods which are not the gold standard. For this reason, it is recommended 
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that these two methods be tested and adjusted to the gold standard for examining the severity of liver 
cirrhosis in the future, which is liver biopsy. 
 
Conclusion 
Based on the results of this research on the conformity between neutrophil/lymphocyte ratio and 
Child-Turcotte-Pugh classification in assessing the severity of liver cirrhosis, it was concluded that there 
was a moderate conformity between neutrophil/lymphocyte ratio and Child-Turcotte-Pugh classification. 
Substantial conformity was found between neutrophil/lymphocyte ratio and Child-Turcotte-Pugh 
classification in the age group of ≤45 years old and in male. 
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